Business● Low17m ago · Nov 12, 2026, 10:34 PM
Mainz Biomed B.V. GAAP EPS of -$0.08 in-line, revenue of $0.97M beats by $0.02M
GlobeAlert Desk · curated from Seeking Alpha Tech · Western Europe
Mainz Biomed B.V. reported GAAP EPS of -$0.08, which was in-line with expectations, and revenue of $0.97 million, surpassing estimates by $0.02 million. This indicates the company's financial performance relative to market predictions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business17m agoJensen Huang’s departure may signal tighter US controls on AI chip exports to ChinaSouth China Morning PostBusiness18m agoMattr Non-GAAP EPS of C$0.43, revenue of C$423.4MSeeking Alpha TechBusiness19m agoSanara MedTech GAAP EPS of -$0.16 misses by $0.18, revenue of $28.43M misses by $1.07MSeeking Alpha TechBusiness19m agoAccelevation Holdings Corp. - Ordinary Shares - Class A reports Q3 resultsSeeking Alpha Tech